INTEGER HOLDINGS CORPORATION Supplier Finance Program Obligation Decrease Settlement
INTEGER HOLDINGS CORPORATION (ITGR) reported Supplier Finance Program Obligation Decrease Settlement of $400.00 thousand for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Payables and Accruals
us-gaap:SupplierFinanceProgramObligationDecreaseSettlement · last filed 2026-08-04
- INTEGER HOLDINGS CORPORATION supplier finance program obligation decrease settlement for the quarter ending 2026-07-03 was $400.00K, a 20.00% decline year-over-year.
- INTEGER HOLDINGS CORPORATION supplier finance program obligation decrease settlement for the quarter ending 2026-04-03 was $500.00K, a 0.00% change year-over-year.
- INTEGER HOLDINGS CORPORATION supplier finance program obligation decrease settlement for the quarter ending 2025-12-31 was $400.00K, a 20.00% decline year-over-year.
- INTEGER HOLDINGS CORPORATION supplier finance program obligation decrease settlement for the quarter ending 2025-09-26 was $600.00K, a 0.00% change year-over-year.
- INTEGER HOLDINGS CORPORATION supplier finance program obligation decrease settlement for fiscal 2025 was $2.00M, a 9.09% decline from fiscal 2024.
- INTEGER HOLDINGS CORPORATION supplier finance program obligation decrease settlement for fiscal 2024 was $2.20M, a 22.22% increase from fiscal 2023.
- INTEGER HOLDINGS CORPORATION supplier finance program obligation decrease settlement for fiscal 2023 was $1.80M, a 100.00% increase from fiscal 2022.
- INTEGER HOLDINGS CORPORATION supplier finance program obligation decrease settlement for fiscal 2022 was $900.00K.
| Period end | Supplier Finance Program Obligation Decrease Settlement 3 month | Supplier Finance Program Obligation Decrease Settlement 6 month | Supplier Finance Program Obligation Decrease Settlement 9 month | Supplier Finance Program Obligation Decrease Settlement 12 month |
|---|---|---|---|---|
| 2026-07-03 | $400.00K 10-Q · filed 2026-08-04 | $900.00K 10-Q · filed 2026-08-04 | $1.30M derived: sum of 3 quarters · filed 2026-08-04 | $1.90M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-04-03 | $500.00K 10-Q · filed 2026-04-30 | $900.00K derived: sum of 2 quarters · filed 2026-04-30 | $1.50M derived: sum of 3 quarters · filed 2026-04-30 | $2.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $1.00M derived: sum of 2 quarters · filed 2026-02-23 | $1.50M derived: sum of 3 quarters · filed 2026-08-04 | $2.00M 10-K · filed 2026-02-23 |
| 2025-09-26 | $600.00K 10-Q · filed 2025-10-23 | $1.10M derived: sum of 2 quarters · filed 2026-08-04 | $1.60M 10-Q · filed 2025-10-23 | $2.10M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-27 | $500.00K 10-Q · filed 2026-08-04 | $1.00M 10-Q · filed 2026-08-04 | $1.50M derived: sum of 3 quarters · filed 2026-08-04 | $2.10M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-28 | $500.00K 10-Q · filed 2026-04-30 | $1.00M derived: sum of 2 quarters · filed 2026-04-30 | $1.60M derived: sum of 3 quarters · filed 2026-04-30 | $2.20M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $1.10M derived: sum of 2 quarters · filed 2026-02-23 | $1.70M derived: sum of 3 quarters · filed 2026-02-23 | $2.20M 10-K · filed 2026-02-23 |
| 2024-09-27 | $600.00K 10-Q · filed 2025-10-23 | $1.20M derived: sum of 2 quarters · filed 2025-10-23 | $1.70M 10-Q · filed 2025-10-23 | $2.20M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-28 | $600.00K 10-Q · filed 2025-07-24 | $1.10M 10-Q · filed 2025-07-24 | $1.60M derived: sum of 3 quarters · filed 2026-02-23 | $2.10M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-29 | $500.00K 10-Q · filed 2024-04-25 | $1.00M derived: sum of 2 quarters · filed 2026-02-23 | $1.50M derived: sum of 3 quarters · filed 2026-02-23 | $1.90M derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $1.00M derived: sum of 2 quarters · filed 2026-02-23 | $1.40M derived: sum of 3 quarters · filed 2026-02-23 | $1.80M 10-K · filed 2026-02-23 |
| 2023-09-29 | $500.00K 10-Q · filed 2024-10-24 | $900.00K derived: sum of 2 quarters · filed 2024-10-24 | $1.30M 10-Q · filed 2024-10-24 | |
| 2023-06-30 | $400.00K 10-Q · filed 2024-07-25 | $800.00K 10-Q · filed 2024-07-25 | ||
| 2023-03-31 | $400.00K 10-Q · filed 2024-04-25 | |||
| 2022-12-31 | $900.00K 10-K · filed 2025-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |